Eli Lilly to invest $1 billion in new contract manufacturing facilities in India; Hyderabad to get manufacturing and quality hub
Eli Lilly will invest over $1 billion in India to establish new contract manufacturing facilities and a manufacturing and quality hub in Hyderabad. This significant investment aims to strengthen global supply capabilities and leverage India's skilled talent pool for producing life-changing medicines, reinforcing Hyderabad's position as a healthcare innovation hub.
Eli Lilly will invest over $1 billion in India to establish new contract manufacturing facilities and a manufacturing and quality hub in Hyderabad. This significant investment aims to strengthen global supply capabilities and leverage India's skilled talent pool for producing life-changing medicines, reinforcing Hyderabad's position as a healthcare innovation hub.
